Home » Health News » Health care CEOs thank Trump administration for capping senior insulin costs to $35 a month
Health care CEOs thank Trump administration for capping senior insulin costs to $35 a month
Health care CEOs thank Trump for helping to cap insulin prices
Humana President and CEO Bruce Broussard discusses the importance of establishing public/private partnerships to ensure prescription drug affordability. American Diabetes Association CEO Tracey Brown explains why establishing insulin affordability is crucial. Eli Lilly CEO David Ricks discusses how senior citizens will benefit from his decreased insulin cost program.
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.
Continue Reading Below
Humana CEO Bruce Broussard and Eli Lilly CEO David Ricks announced their support for President Trump's decision to lower seniors' insulin costs to $35 a month.
"I want to thank the administration for continuing to pick on large issues like this and bringing in the private enterprise to assist in that," Broussard said.